Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Semmler
Thomas Reiberger
Bernhard Scheiner

Showing results (1-10 of 641) with videos related to

Pageof 65
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2022
ReplyGeorg Semmler, Thomas Reiberger, Bernhard Scheiner
European Journal of Radiology|December 14, 2020
Letter to Lavian and colleaguesGeorg Semmler, Thomas Reiberger
Journal of Hepatocellular Carcinoma|December 8, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Lorenz Balcar, Bernhard Scheiner, et al.
Scientific Reports|May 17, 2024
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failurePatrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 14, 2025
Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong TrackLorenz Balcar, Nina Dominik, Behrang Mozayani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisLorenzo Lani, Bernhard Scheiner, Matthias Pinter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Letter to the Editor: Dynamics in liver stiffness to assess response in MASLD patients treated with resmetirom-One piece of the puzzle?Georg Semmler, Maja Thiele, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' replyMattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Pageof 65

Showing results (1-10 of 641) with videos related to

Sort By:
Pageof 65
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2022
ReplyGeorg Semmler, Thomas Reiberger, Bernhard Scheiner
European Journal of Radiology|December 14, 2020
Letter to Lavian and colleaguesGeorg Semmler, Thomas Reiberger
Journal of Hepatocellular Carcinoma|December 8, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Lorenz Balcar, Bernhard Scheiner, et al.
Scientific Reports|May 17, 2024
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failurePatrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 14, 2025
Elevated Hepatic Copper Content in Porto-Sinusoidal Vascular Disorder (PSVD): Leading Down a Wrong TrackLorenz Balcar, Nina Dominik, Behrang Mozayani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisLorenzo Lani, Bernhard Scheiner, Matthias Pinter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Letter to the Editor: Dynamics in liver stiffness to assess response in MASLD patients treated with resmetirom-One piece of the puzzle?Georg Semmler, Maja Thiele, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' replyMattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Pageof 65